万古霉素粉能否降低生长中脊柱手术的手术部位感染?一项初步研究
该回顾性研究纳入2010至2016年因早发性脊柱侧凸接受手术的36例患者共191次手术,比较术中是否使用万古霉素粉的手术部位感染率。对照组87次手术中12次感染(每次手术感染率13.8%),万古霉素组104次手术中5次感染(4.8%),差异有统计学意义(p=0.038)。作者认为万古霉素粉与手术部位感染风险显著降低相关。
要点
- 对照组每次手术感染率为13.8%,万古霉素组为4.8%,差异有统计学意义(p=0.038)。
- 预防1例手术部位感染需使用万古霉素粉的手术次数为10.9次。
- 36例患者中14例(39%)发生至少1次深部手术部位感染,仅2例发生多次急性感染。
核心结论
- 在早发性脊柱侧凸的生长中脊柱手术中使用万古霉素粉与手术部位感染风险显著降低相关。
- 即使既往手术未使用万古霉素粉,其似乎仍然有效。
研究设计与样本
- 回顾性研究,纳入2010至2016年在本中心因早发性脊柱侧凸治疗的患者。
- 2010年更新了标准化的围手术期生长中脊柱诊疗路径,此后唯一改变是逐步引入切口内万古霉素粉。
- 按手术是否使用万古霉素粉分为对照组(未使用)和实验组(使用),其余围手术期管理相同。
- 纳入初次置入、翻修、延长手术及最终融合手术,比较两组每次手术的术后手术部位感染率。
- 共36例患者、191次手术符合纳入标准。
主要发现
- 两组临床与影像学资料基本相同。
- 研究期间36例患者中14例(39%)发生至少1次深部手术部位感染,仅2例发生多次急性感染。
- 对照组87次手术中12次感染,每次手术感染率为13.8%。
- 万古霉素组104次手术中5次感染,每次手术感染率为4.8%。
- 每次手术感染率差异有统计学意义(p=0.038),预防1例手术部位感染需使用万古霉素粉的手术次数为10.9次。
关键数值与推荐
- 对照组每次手术手术部位感染率为13.8%(87次手术中12次感染)。
- 万古霉素组每次手术手术部位感染率为4.8%(104次手术中5次感染)。
- 两组感染率差异p=0.038。
- 需使用万古霉素粉预防1例手术部位感染的手术次数为10.9次。
- 证据等级为治疗性证据III级。
临床怎么用
- 作者认为在早发性脊柱侧凸的生长中脊柱手术中使用万古霉素粉与手术部位感染风险显著降低相关,且即使既往手术未使用万古霉素粉似乎仍然有效。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vancomycin powder has been demonstrated to be safe in children, and yet there are no data on its use to reduce surgical site infections (SSIs) in surgery for early-onset scoliosis. METHODS: We performed a retrospective study of our patients treated for early-onset scoliosis in the period of 2010 to 2016. In 2010, we updated our standardized perioperative growing spine care path. The only later change was the gradual introduction of intrawound vancomycin powder. Procedures were categorized into either the control group (without vancomycin powder) or the experimental group (with vancomycin powder), with otherwise identical perioperative management. Initial insertion, revision, and lengthening procedures and final fusions were included. We compared the rate of postoperative SSIs per procedure between the groups. RESULTS: Thirty-six patients who underwent 191 procedures met the inclusion criteria. The clinical and radiographic data were essentially the same between the groups. During the study period, 14 (39%) of the 36 patients developed ≥1 deep SSI. Only 2 patients had multiple acute infections. There were 87 procedures with 12 infections in the control group (SSI rate of 13.8% per procedure), while there were 104 procedures with 5 infections in the vancomycin group (4.8% per procedure). The difference in the SSI rate per procedure was significant (p = 0.038). The number of individual procedures needed to be performed using vancomycin to prevent an SSI was 10.9. CONCLUSIONS: The use of vancomycin powder in growing spine surgery for early-onset scoliosis is associated with a significant decreased risk of SSI. It appears to be effective even when previous surgeries have been performed without its use. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
引用
- Thompson GH, Poe-Kochert C, Hardesty CK, et al. Does Vancomycin Powder Decrease Surgical Site Infections in Growing Spine Surgery?: A Preliminary Study. J Bone Joint Surg Am. 2018. PMID: 29557862. doi:10.2106/JBJS.17.00459
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。